This is part I of a three-part series. All references are provided at the conclusion of each article. Before Biden left the office of president, the Department of Health and Human Services awarded $590 million to pharmaceutical company Moderna to develop multiple modified mRNA injections for several “avian influenza viruses” including H5N1 and H7N9. As …